Intersect ENT CEO Thomas West's 2019 pay jumps 262% to $7.2M
Intersect ENT reports 2019 executive compensation
By ExecPay News
Published: April 20, 2021
Intersect ENT reported fiscal year 2019 executive compensation information on April 20, 2021.
In 2019, 11 executives at Intersect ENT received on average a compensation package of $2.4M, a 52% increase compared to previous year.
Average pay of disclosed executives at Intersect ENT
Thomas A. West, Chief Executive Officer, received $7.2M in total. 55% of West's compensation, or $3.9M, was in option awards. West also received $100K in bonus, $96K in non-equity incentive plan, $237K in salary, $2.8M in stock awards, as well as $3K in other compensation.
Lisa D. Earnhardt, Chief Executive Officer, received a compensation package of $3.6M, which increased by 2% compared to previous year. 63% of the compensation package, or $2.3M, was in option awards.
Kieran T. Gallahue, Chief Executive Officer, earned $3M in 2019.
Richard A. Meier, Chief Financial Officer, received $3M in 2019.
David A. Lehman, General Counsel, earned $2.1M in 2019, a 67% increase compared to previous year.
Jeryl L. Hilleman, Chief Financial Officer, received $2M in 2019, which increases by 22% compared to 2018.
Robert H. Binney, Jr, Former Chief Commercial Officer, earned $1.2M in 2019.
Robert H. Binney, Chief Commercial Officer, received $1.2M in 2019.
Susan P. Stimson, Former Chief Strategy Officer, earned $1.1M in 2019, a 20% increase compared to previous year.
Gwen R. Carscadden, Chief People Officer, received $1.1M in 2019, which increases by 19% compared to 2018.
Christine R. Kowalski, Chief Operating Officer, earned $822K in 2019, a 35% decrease compared to previous year.
Related executives
Christine Kowalski
Intersect ENT
Chief Operating Officer
Robert Binney
Intersect ENT
Former Chief Commercial Officer
Thomas West
Intersect ENT
Chief Executive Officer
Kieran Gallahue
Intersect ENT
Chief Executive Officer
Lisa Earnhardt
Intersect ENT
Chief Executive Officer
Richard Meier
Intersect ENT
Chief Financial Officer
Jeryl Hilleman
Intersect ENT
Chief Financial Officer
Robert Binney
Intersect ENT
Chief Commercial Officer
You may also like
Source: SEC filing on April 20, 2021.